InvestorsHub Logo
Followers 122
Posts 6384
Boards Moderated 0
Alias Born 08/17/2014

Re: Papa Tweek1 post# 33621

Tuesday, 04/21/2015 8:13:20 AM

Tuesday, April 21, 2015 8:13:20 AM

Post# of 705317
No. They'd be allowed to release overall news on the study, embargo allows for that.

Honestly, I think they passed on ASCO as Direct Ph I was not final as of April late submission deadline. Remember they added a few patients at the end of the trial, and those patients last vaccine treatments would be in May assuming they're still active patients (August enrollees). Those patients data, even after the last treatment, then needs to age a few month I suspect they're holding out for the next conference in August/September. (They'll still be at ASCO just not in a presenter capacity.)

Most of the patients were enrolled between March and June.  And, we actually over enrolled the trial. The trial exceeded its maximum.  So we had some other patients enrolled in July and August.  But once the patient enrolled it takes about a month for them to go through the blood draw, have the one week product manufacturing, and get scheduled for their injections to start. So call it a month of preparation, and then it's an eight month treatment regimen. Right, so you can do the math. The patients who were the last ones in, who came in June and July will be finishing their treatment regimen in March and April. - LP

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News